Adagene Inc (ADAG)
2.39
+0.04
(+1.70%)
USD |
NASDAQ |
Apr 26, 16:00
2.39
0.00 (0.00%)
After-Hours: 20:00
Adagene Cash and Short Term Investments (Quarterly): 109.93M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 109.93M |
| June 30, 2023 | 128.76M |
| December 31, 2022 | 143.76M |
| June 30, 2022 | 168.04M |
| December 31, 2021 | 174.39M |
| Date | Value |
|---|---|
| June 30, 2021 | 208.27M |
| December 31, 2020 | 75.15M |
| September 30, 2020 | 82.89M |
| December 31, 2019 | 100.53M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
75.15M
Minimum
Dec 2020
208.27M
Maximum
Jun 2021
132.41M
Average
128.76M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 11.07B |
| CASI Pharmaceuticals Inc | 30.77M |
| Zai Lab Ltd | 806.45M |
| I-MAB | 406.06M |
| Gracell Biotechnologies Inc (DELISTED) | 234.08M |